Clinical Trial Update: Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin [Phase 2]

View source ↗

Summary

Phase 2 trial update suggesting hyper-thermia may enhance anti-tumor efficacy of trabectedin in sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN